Aurora Investment Counsel’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-26,384
Closed -$1.24M – 109
2025
Q3
$1.24M Buy
26,384
+1,804
+7% +$93.5K 0.65% 84
2025
Q2
$1.28M Buy
24,580
+6,930
+39% +$380K 0.67% 80
2025
Q1
$1.07M Buy
17,650
+517
+3% +$33.3K 0.59% 83
2024
Q4
$1.17M Buy
17,133
+1,841
+12% +$128K 0.64% 79
2024
Q3
$1.1M Buy
+15,292
New +$1.08M 0.6% 87
2014
Q4
$288K Sell
6,413
-19,745
-75% -$828K 0.18% 98
2014
Q3
$964K Sell
26,158
-242
-0.9% -$9.6K 0.63% 82
2014
Q2
$1.17M Buy
26,400
+835
+3% +$37.9K 0.73% 78
2014
Q1
$1.11M Sell
25,565
-12,631
-33% -$563K 0.71% 78
2013
Q4
$1.62M Buy
38,196
+9,520
+33% +$362K 1.07% 50
2013
Q3
$974K Sell
28,676
-40
-0.1% -$1.3K 0.71% 77
2013
Q2
$917K Buy
+28,716
New +$932K 0.71% 77

Other funds holding CNMD

Aurora Investment Counsel's CNMD Position: Q4 2025 in Review

Aurora Investment Counsel sold out of CONMED (CNMD) in Q4 2025, closing a stake of 26,384 shares — an estimated $1.24M sold.

Aurora Investment Counsel first reported a position in CNMD in Q2 2013 and held it in 12 quarters. The position peaked at $1.62M in Q4 2013. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • Aurora Investment Counsel reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • Aurora Investment Counsel sold 26,384 CONMED shares in Q4 2025, an estimated $1.24M.
  • Aurora Investment Counsel first reported a position in CONMED in Q2 2013 and held it in 12 quarters.
  • Aurora Investment Counsel's CONMED position peaked at $1.62M in Q4 2013.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Aurora Investment Counsel's 13F filing for Q4 2025, filed 13 Feb 2026.